Table 2 Performance of the seven anthropometric indicators in the identification of hepatic steatosis and fibrosis patients.

From: Association of the fat mass index with hepatic steatosis and fibrosis: evidence from NHANES 2017–2018

Outcome

Indicator

Sensitivity

Specificity

AUC

95%CI

P value

Steatosis

FMI1

0.845

0.547

0.696

0.678–0.714

< 0.001

FMI2

0.801

0.562

0.681

0.662–0.700

< 0.001

WWI

0.798

0.627

0.713

0.694–0.731

< 0.001

BMI

0.885

0.536

0.711

0.693–0.728

< 0.001

BF%

0.705

0.519

0.612

0.592–0.632

< 0.001

WHR

0.735

0.706

0.720

0.702–0.739

< 0.001

ASMI

0.649

0.668

0.709

0.688–0.730

< 0.001

Fibrosis

FMI1

0.617

0.751

0.726

0.711–0.741

< 0.001

FMI2

0.659

0.690

0.715

0.700–0.731

< 0.001

WWI

0.753

0.610

0.717

0.712–0.742

< 0.001

BMI

0.897

0.333

0.615

0.603–0.627

< 0.001

BF%

0.734

0.471

0.630

0.613–0.647

< 0.001

WHR

0.625

0.695

0.715

0.700–0.730

< 0.001

ASMI

0.800

0.538

0.717

0.702–0.732

< 0.001

  1. FMI1, fat mass index ([fat mass]/height2); FMI2, fat mass index ([fat mass]/height3); WWI, weight-adjusted-waist index; BMI, body mass index; BF%, percentage of body fat; WHR, waist-to-hip ratio; ASMI, appendicular skeletal muscle index.
  2. Significant values are in bold.
Back to article page